NMTC
NASDAQNeuroOne Medical Technologies Corporation
SectorHealth CareIndustryMedical/Dental Instruments
Website
News25/Ratings4
News · 26 weeks36+67%
2025-10-262026-04-19
Mix2390d
- Insider14(61%)
- SEC Filings7(30%)
- Dividends1(4%)
- Other1(4%)
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by NeuroOne Medical Technologies CorporationSCHEDULE 13G - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Mills Jason Richard4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mathiesen Jeffrey S4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Buckman Paul4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Andrle Edward4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERSEC Form 4 filed by Christianson Mark4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Mertens Steve4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 4 filed by Rosa David A4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECSEC Form DEF 14A filed by NeuroOne Medical Technologies CorporationDEF 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- PRNext-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer SegmentsIssued on behalf of Doseology Sciences Inc.Equity-Insider.com VANCOUVER, BC, March 5, 2026 /CNW/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sc
- INSIDERChief Business Officer Wambeke David J. bought $670,400 worth of shares (1,000,000 units at $0.67) (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERSEC Form 3 filed by new insider Wambeke David J.3 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECSEC Form PRE 14A filed by NeuroOne Medical Technologies CorporationPRE 14A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERChief Technology Officer Mertens Steve covered exercise/tax liability with 7,376 shares, decreasing direct ownership by 5% to 153,047 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERBusiness Development Director Christianson Mark covered exercise/tax liability with 1,812 shares, decreasing direct ownership by 0.79% to 228,920 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- INSIDERCEO and President Rosa David A covered exercise/tax liability with 71,325 shares, decreasing direct ownership by 6% to 1,082,590 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)
- SECNeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECSEC Form 10-Q filed by NeuroOne Medical Technologies Corporation10-Q - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- SECAmendment: SEC Form 10-K/A filed by NeuroOne Medical Technologies Corporation10-K/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
- INSIDERChief Technology Officer Mertens Steve covered exercise/tax liability with 906 shares, decreasing direct ownership by 0.56% to 160,423 units (SEC Form 4)4 - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Issuer)